HRT Labels Presumed Adequate Under N.J. Law, Court Affirms

TRENTON, N.J. - A New Jersey appellate court has affirmed summary judgment to Wyeth Inc. in two hormone replacement therapy cases, finding that the plaintiffs failed to provide evidence to rebut the assumption that the warning labels on three FDA-approved HRT drugs were adequate. Bailey v. Wyeth Inc., et al., Nos. A-6230-07T1 and A-6251-07T1 (N.J. App. Div.).

On Sept. 29, the Superior Court of New Jersey, Appellate Division adopted the trial court's finding that because there is no evidence that Wyeth ever intentionally withheld any risk information from the Food and Drug Administration, nor manipulated any safety data after the …